Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.

José Ramón SantosA Cozzi-LepriA PhillipsS De WitC PedersenP ReissA BlaxhultA LazzarinM SluzhynskaC OrkinC DuvivierJ BognerP Gargalianos-KakolyrisP SchmidG HassounI KhromovaM BeniowskiV HadziosmanovicD SedlacekR ParedesJ D Lundgrennull null

Published in: HIV medicine (2018)

Although confounding by indication and calendar year cannot be completely ruled out, in ART-experienced subjects the long-term effectiveness of DRV/r-containing regimens appears to be greater than that of ATZ/r and LPV/r.

Keyphrases

antiretroviral therapy
hiv infected
randomized controlled trial
systematic review
human immunodeficiency virus
hiv infected patients
hiv positive
hiv aids